Targeted Oncology™ launches Oncology Icons award program to recognize community oncologists
The program highlights the exceptional work of oncology providers.
CRANBURY, N.J., 1 June 2023-- Targeted Oncology, a multimedia resource that offers engaging content and expert opinions on standard and emerging treatments in the field of oncology, is pleased to announce the launch of its Oncology Icons award program. Designed to honor the outstanding achievements of community oncologists, this program aims to highlight their exceptional work and provide valuable opportunities for collaboration and knowledge sharing.
Submissions will be accepted on a rolling basis throughout the year. To be eligible for the July 2023 award, nominations must be submitted no later than June 30, 2023. This recognition is open to eligible physicians who are oncologists/hematologists practicing in the community setting and have a minimum of seven years of experience. Nominees must be endorsed by a practice, professional organization or fellow physician.
Selected honorees will be featured in a quarterly article published on the Targeted Oncology website and in Targeted Therapies in Oncology™, a renowned publication in the field. Along with the recognition, recipients will have the chance to share their unique expertise with the oncology community through several opportunities.
The opportunities offered to honorees include:
- The chance to submit bylines to Targeted Oncology for up to two years after their recognition;
- An invitation to join the Targeted Therapies in Oncology editorial board;
- Being one of the first experts Targeted Oncology contacts for quotes related to FDA approvals, guidelines updates and clinical trial updates;
- An invitation to a virtual interview with Targeted Oncology to discuss work at their practice/institution;
- An invitation to participate in a Targeted Chat on Twitter Spaces to discuss cancer types and treatments;
- An open invitation from Targeted Oncology to be interviewed on video at medical meetings for up to two years after their recognition;
- Invitation to share topics the honoree thinks are important to cover and give honorees the option to provide commentary.
Organizations and key opinion leaders that know of physicians who are making important strides in community oncology are welcome to submit a nomination. The nomination submission must be a minimum of 150 words and thoroughly describe how the nominee has demonstrated exceptional expertise, compassion and diligence while working as an oncologist/hematologist.
To submit a nomination for the Oncology Icons award program, please click here.
AboutTargeted Oncology
Targeted Oncology, a leading resource for oncologists and hematologists, empowers practice-changing outcomes through innovative learning formats and peer engagements. Its journals, Targeted Therapies in Oncology™ and Peers & Perspectives® in Oncology, are delivered 18 times a year. TargetedOnc.com offers daily content, an e-newsletter subscription, and hosts 500+ virtual and in-person events annually, fostering engaging discussions among oncology peers. Targeted Oncology is a brand of MJH Life Sciences®, the largest privately held, independent, full-service medical media company in North America, delivering trusted health care news.
Media Contact:
Lauren Garafola
MJH Life Sciences
lgarafola@mjhlifesciences.com
Maen Hussein: ‘Every Success Motivates Us to Do Even Better’
November 16th 2023In an interview with Targeted Oncology, Maen Hussein, MD, a Q3 2023 Oncology Icons honoree, discusses his path to the community oncology setting and highlights upcoming trends in oncology he feels will improve patient outcomes.
Read More
